Benzinga | May 11, 2021 06:36AM EDT

Beam Therapeutics Q1 EPS $(3.35) Down From $(1.03) YoY

Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(3.35) per share. This is a 225.24 percent decrease over losses of $(1.03) per share from the same period last year.